Insider filing · TRDA
Entrada Therapeutics, Inc.
TRDA · Healthcare · 31 filings in 24 months
ticker →
MPM BioVentures 2014, L.P. sold $617K of Entrada Therapeutics (TRDA)
Executed Sep 1, disclosed Sep 3, 2 days later.
Value, as filed
$617K
86,482 sh across 3 lots
Executed
Sep 1
the trade date, as filed
Disclosed
Sep 3
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MP
MPM BioVentures 2014, L.P.
10% owner
profile →
MPM BioVentures 2014, L.P. (10% owner) filed 4 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 4 sales), most often in Entrada Therapeutics, Inc. (TRDA). The largest single filing was $1.9M of TRDA (259,837 sh across 3 lots, as filed), executed Sep 4.
The name
TRDAHealthcare · Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new c…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by MPM BioVentures 2014, L.P. in TRDA
TRDASALE
Entrada Therapeutics, Inc.
$1.9M259,837 sh across 3 lots
Exec Sep 4
Filed Sep 9 · 7:23 PM ET TRDASALE Entrada Therapeutics, Inc. $590K
83,181 sh across 2 lots
Exec Aug 27
Filed Aug 31 · 6:25 PM ET TRDASALE Entrada Therapeutics, Inc. $462K
62,714 sh across 3 lots
Exec Aug 24
Filed Aug 26 · 9:28 PM ET